Skip to main content

Affinity Asset Advisors, LLC

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1773195 NEW YORK, NY

Position in KPTI

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$2,785,000
-$3,762,272 QoQ
Shares Held
500,000
-43.8% QoQ
Ownership
2.21%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Derivatives in KPTI

reported options exposure · as of Sep 30, 2025
CallValue
$1,030,704
CallShares
157,600
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Affinity Asset Advisors, LLC holds $1,535,632,022 across 81 Biotechnology names. KPTI ranks #65 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KPTI

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,785,000 500,000
2026-01-22 $11,374,930 1,713,092
2025-12-31 $6,547,272 889,575
2025-09-30 $1,030,704 157,600
2025-06-30 $678,825 157,500
2025-04-03 $2,563,904 664,224